Nasdaq

20 stories about Nasdaq
רן פוליאקין מנכ"ל ננוקס

Will Nanox be the next Israeli hit on Nasdaq?

02.08.20|Meir Orbach
Medical imaging company plans to raise $125 million. The valuation of the company is estimated to be at least $600 million
עמרי לביא מייסד אורקסטרה ו NSO

Founders Group, linked to NSO co-founders revealed as early investor in Vroom

07.07.20|Meir Orbach
Used cars online retailer Vroom recently listed on Nasdaq and is currently traded at a $6.4 billion market cap
עמרי אורגד לומינטי נטוורקס

How economic uncertainty is pushing financial institutions towards alternative data

16.06.20|Omri Orgad
Derived from non-traditional sources for financial information, alternative data is becoming an increasingly important tool for investors, in the aftermath of Covid-19, due to a lack of relevant up-to-date data that reflects the current marketplace in real time
איגוואזיו iguazio  מימין אסף סומך ירון חביב ירון שגב

Nasdaq-listed NetApp to incorporate technology by Israeli startup Iguazio

10.06.20|Meir Orbach
Iguazio offers data management services and artificial intelligence tools designed to improve the performance, security, and scalability of machine learning applications
מימין מייסדי Vroom אלון בלוך ו אלי וורטמן

Online Used Car Marketplace Vroom Triples its Aim for Nasdaq IPO to $318 Million

03.06.20|Meir Orbach
The company develops an online direct-to-consumer platform that offers low-mileage reconditioned vehicles
מימין מייסדי Vroom אלון בלוך ו אלי וורטמן

Online Used Car Merchant Vroom Wants to Raise $100 Million on Nasdaq

19.05.20|Meir Orbach
According to its prospectus, the New York-based company made $1.2 billion in revenue in 2019, reporting a total of $143 million in net loss
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
חברת פורסקאוט שנמכרה לקרן הפרייבט אקוויטי

Delisting Will Allow Forescout to Do Things a Public Company Can't, Says Exec

09.02.20|Meir Orbach
Forescout co-founder Oded Comay spoke to Calcalist days after the company's $1.9 billion acquisition
נאסדק

How Will Israel Fare When the Nasdaq Jet Finally Runs out of Fuel

05.02.20|Sophie Shulman
Wall Street just had its strongest decade of gains. Should it crash, would the tech-dependent Israeli economy survive unscathed?
נאסדק

Itamar Medical Closes Nasdaq Public Offering at $40.25 Million

05.02.20|CTech
The medical diagnosis company initially looked to raise $30 million to fund its sales and marketing operations as well as product development and clinical trials
default image

Itamar Medical Upsizes Nasdaq Public Offering to $35 Million

02.02.20|Tzally Greenberg
The Nasdaq and Tel Aviv-listed medical diagnosis company originally planned to raise $30 million
אבישי אברהמי מייסד ו מנכל וויקס wix

Israelis Dream of Big U.S. IPOs, but Are Swallowed by M&As Instead

30.01.20|Sophie Shulman
Over the past two decades, Israeli companies raised just $10 billion on Wall Street, compared to the $380 billion that changed hands as part of M&As. A new Barclays report sheds light on how Israeli companies take on New York
נאסדק

Ayala Pharmaceuticals Headed for Nasdaq IPO

07.01.20|Golan Hazani
The Israel-based cancer treatment developer wants to raise $100 million according to a $400 million company valuation
משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Company InMode in Talks for Secondary Offering

23.12.19|Golan Hazani
The Israel-based company listed on Nasdaq in August at a $450 million company valuation but has since reached a $1.3 billion market capitalization
קולין חואנג מייסד פינדואודואו Pinduoduo אופיר דור

The Chinese Giant That Turns Shopping into a Role-Playing Game

11.11.19|Ofir Dor
Pinduoduo’s collective buying-based business model succeeds where Groupon failed, making it a bright new star on the Chinese e-commerce scene and one of Nasdaq’s hottest tickets
נאסדק

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

15.10.19|CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO

11.08.19|Golan Hazani
InMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million
נאסדק

Medical Aesthetic Devices Manufacturer InMode Looking to Raise $75 Million on Nasdaq

14.07.19|CTech
In June, Calcalist reported that InMode is looking to list on Nasdaq according to a company valuation of $400 million to $500 million
default image

SEC Sends Enforcement Action Notice to Interception Firm Ability

23.06.19|Tzally Greenberg
The notice is the result of an anti-fraud violation investigation that has been ongoing since 2017 and pertains to Ability's 2015 merger with shelf company Cambridge
נאסדק

Kornit Digital Prices Public Offering at $119 Million

16.06.19|Tzally Greenberg
The Nasdaq-listed printer manufacturer will issue 11% of its stock at $27.5 per share, slightly under its Friday closing price of $28.39